Cefazolin Injection, Powder, For Solution
Product Images NDC 72572-055
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Cefazolin (NDC 72572-055). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Civica, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Plb851-civ/1 (Cefazolin For Injection Usp Civica 2)
Cefazolin for Injection, USP is a medication used for intravenous or intramuscular use. This medication comes in a 1 gram* per vial dosage, and patients should be shaken well before use. The recommended dosage is 250g every 010w and should not be given to patients with a sodium and sulfur allergy. Patients who are administering this medication should ensure that the vial is kept at room temperature to maintain the medication's integrity. For more information on administration, patients should refer to the packaging insert provided.*
Plb852-civ/1 (Cefazolin For Injection Usp Civica 3)
Cefazolin for Injection, USP is available in a box of 25 vials, each containing sterile cefazolin sodium equivalent to 1 gram cefazolin. The usual adult dosage is 250 mg to 1 gram every 6-10 hours for intravenous or intramuscular use. The reconstituted solution is stable for 24 hours at room temperature or for 10 days in the refrigerator. The reconstituted solutions may range in color from pale yellow to yellow without a change in potency. It is distributed by Civica, Inc., and manufactured by Hikima Famacéutica, Portugal.*
Layout 1 (Cefazolin For Injection Usp Civica 4)
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.